Works matching AU Williams, David S.

Results: 117
    1
    2

    Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

    Published in:
    2021
    By:
    • Arulananda, Surein;
    • O'Brien, Megan;
    • Evangelista, Marco;
    • Harris, Tiffany J.;
    • Steinohrt, Nikita S.;
    • Jenkins, Laura J.;
    • Walkiewicz, Marzena;
    • O'Donoghue, Robert J. J.;
    • Poh, Ashleigh R.;
    • Thapa, Bibhusal;
    • Williams, David S.;
    • Leong, Trishe;
    • Mariadason, John M.;
    • Li, Xia;
    • Cebon, Jonathan;
    • Lee, Erinna F.;
    • John, Thomas;
    • Fairlie, W. Douglas
    Publication type:
    Correction Notice
    3

    BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

    Published in:
    Cell Death Discovery, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41420-020-00348-1
    By:
    • Arulananda, Surein;
    • O'Brien, Megan;
    • Evangelista, Marco;
    • Harris, Tiffany J.;
    • Steinohrt, Nikita S.;
    • Jenkins, Laura J.;
    • Walkiewicz, Marzena;
    • O'Donoghue, Robert J. J.;
    • Poh, Ashleigh R.;
    • Thapa, Bibhusal;
    • Williams, David S.;
    • Leong, Trishe;
    • Mariadason, John M.;
    • Li, Xia;
    • Cebon, Jonathan;
    • Lee, Erinna F.;
    • John, Thomas;
    • Douglas Fairlie, W.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03952-y
    By:
    • Chionh, Fiona;
    • Gebski, Val;
    • Al-Obaidi, Sheren J.;
    • Mooi, Jennifer K.;
    • Bruhn, Maressa A.;
    • Lee, Chee K.;
    • Chüeh, Anderly C.;
    • Williams, David S.;
    • Weickhardt, Andrew J.;
    • Wilson, Kate;
    • Scott, Andrew M.;
    • Simes, John;
    • Hardingham, Jennifer E.;
    • Price, Timothy J.;
    • Mariadason, John M.;
    • Tebbutt, Niall C.
    Publication type:
    Article
    13
    14
    15
    16
    17

    BCL-X<sub>L</sub> inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF<sup>V600E</sup> colorectal cancer.

    Published in:
    Cell Death & Disease, 2024, v. 15, n. 3, p. 1, doi. 10.1038/s41419-024-06478-z
    By:
    • Jenkins, Laura J.;
    • Luk, Ian Y.;
    • Chionh, Fiona;
    • Tan, Tao;
    • Needham, Kristen;
    • Ayton, Jamieson;
    • Reehorst, Camilla M.;
    • Vukelic, Natalia;
    • Sieber, Oliver M.;
    • Mouradov, Dmitri;
    • Gibbs, Peter;
    • Williams, David S.;
    • Tebbutt, Niall C.;
    • Desai, Jayesh;
    • Hollande, Frédéric;
    • Dhillon, Amardeep S.;
    • Lee, Erinna F.;
    • Merino, Delphine;
    • Fairlie, W. Douglas;
    • Mariadason, John M.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Spata7 is a retinal ciliopathy gene critical for correct RPGRIP1 localization and protein trafficking in the retina.

    Published in:
    Human Molecular Genetics, 2015, v. 24, n. 6, p. 1584, doi. 10.1093/hmg/ddu573
    By:
    • Eblimit, Aiden;
    • Nguyen, Thanh-Minh T.;
    • Chen, Yiyun;
    • Esteve-Rudd, Julian;
    • Zhong, Hua;
    • Letteboer, Stef;
    • Van Reeuwijk, Jeroen;
    • Simons, David L.;
    • Ding, Qian;
    • Wu, Ka Man;
    • Li, Yumei;
    • Van Beersum, Sylvia;
    • Moayedi, Yalda;
    • Xu, Huidan;
    • Pickard, Patrick;
    • Wang, Keqing;
    • Gan, Lin;
    • Wu, Samuel M.;
    • Williams, David S.;
    • Mardon, Graeme
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides.

    Published in:
    Human Molecular Genetics, 2008, v. 17, n. 22, p. 3474, doi. 10.1093/hmg/ddn240
    By:
    • Stokin, Gorazd B.;
    • Almenar-Queralt, Angels;
    • Gunawardena, Shermali;
    • Rodrigues, Elizabeth M.;
    • Falzone, Tomás;
    • Kim, Jungsu;
    • Lillo, Concepción;
    • Mount, Stephanie L.;
    • Roberts, Elizabeth A.;
    • McGowan, Eileen;
    • Williams, David S.;
    • Goldstein, Lawrence S.B.
    Publication type:
    Article
    45

    Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.

    Published in:
    Human Molecular Genetics, 2008, v. 17, n. 15, p. 2405, doi. 10.1093/hmg/ddn140
    By:
    • Jacobson, Samuel G.;
    • Cideciyan, Artur V.;
    • Aleman, Tomas S.;
    • Sumaroka, Alexander;
    • Roman, Alejandro J.;
    • Gardner, Leigh M.;
    • Prosser, Haydn M.;
    • Mishra, Monalisa;
    • Bech-Hansen, N. Torben;
    • Herrera, Waldo;
    • Schwartz, Sharon B.;
    • Liu, Xue-Zhong;
    • Kimberling, William J.;
    • Steel, Karen P.;
    • Williams, David S.
    Publication type:
    Article
    46

    In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse.

    Published in:
    Human Molecular Genetics, 2006, v. 15, n. 11, p. 1847, doi. 10.1093/hmg/ddl107
    By:
    • Chang, Bo;
    • Khanna, Hemant;
    • Hawes, Norman;
    • Jimeno, David;
    • He, Shirley;
    • Lillo, Concepcion;
    • Parapuram, Sunil K.;
    • Cheng, Hong;
    • Scott, Alison;
    • Hurd, Ron E.;
    • Sayer, John A.;
    • Otto, Edgar A.;
    • Attanasio, Massimo;
    • O'Toole, John F.;
    • Jin, Genglin;
    • Shou, Chengchao;
    • Hildebrandt, Friedhelm;
    • Williams, David S.;
    • Heckenlively, John R.;
    • Swaroop, Anand
    Publication type:
    Article
    47
    48
    49
    50